The progression of regional atrophy in premanifest and early Huntington's disease: a longitudinal voxel-based morphometry study
暂无分享,去创建一个
Josephine Barnes | Sarah J Tabrizi | Rachael I Scahill | N. Fox | R. Barker | J. Barnes | S. Tabrizi | R. Scahill | Susie M.D. Henley | G. Ridgway | E. Wild | N. Hobbs | Roger A Barker | Gerard R Ridgway | Edward J Wild | Nicola Z Hobbs | Susie M D Henley | Nick C Fox | R. Barker
[1] J. Vonsattel,et al. Morphometric Demonstration of Atrophic Changes in the Cerebral Cortex, White Matter, and Neostriatum in Huntington's Disease , 1988, Journal of neuropathology and experimental neurology.
[2] Jane S. Paulsen,et al. Unified Huntington's disease rating scale: Reliability and consistency , 1996, Movement disorders : official journal of the Movement Disorder Society.
[3] M. MacDonald,et al. CAG repeat number governs the development rate of pathology in Huntington's disease , 1997, Annals of neurology.
[4] Nick C Fox,et al. Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. , 1997, Computer methods and programs in biomedicine.
[5] Nick C Fox,et al. Modeling brain deformations in Alzheimer disease by fluid registration of serial 3D MR images. , 1998, Journal of computer assisted tomography.
[6] G. M. Halliday,et al. Regional Specificity of Brain Atrophy in Huntington's Disease , 1998, Experimental Neurology.
[7] Alan C. Evans,et al. A nonparametric method for automatic correction of intensity nonuniformity in MRI data , 1998, IEEE Transactions on Medical Imaging.
[8] Karl J. Friston,et al. Voxel-Based Morphometry—The Methods , 2000, NeuroImage.
[9] G. Pearlson,et al. Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.
[10] Nick C Fox,et al. Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects. , 2000, Archives of neurology.
[11] Nick C Fox,et al. Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging. , 2001, AJNR. American journal of neuroradiology.
[12] Nick C Fox,et al. Mapping the evolution of regional atrophy in Alzheimer's disease: Unbiased analysis of fluid-registered serial MRI , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[13] Jason Brandt,et al. Neuropsychological manifestations of the genetic mutation for Huntington's disease in presymptomatic individuals , 2002, Journal of the International Neuropsychological Society.
[14] Thomas E. Nichols,et al. Thresholding of Statistical Maps in Functional Neuroimaging Using the False Discovery Rate , 2002, NeuroImage.
[15] L. Raymond,et al. Caudate volume as an outcome measure in clinical trials for Huntington’s disease: a pilot study , 2003, Brain Research Bulletin.
[16] Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis , 2003 .
[17] Jane S. Paulsen,et al. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length , 2004, Clinical genetics.
[18] Emma B. Lewis,et al. Correction of differential intensity inhomogeneity in longitudinal MR images , 2004, NeuroImage.
[19] Jane S. Paulsen,et al. In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease , 2004, Neurology.
[20] Wilhelm Gaus,et al. Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis , 2004, Neurology.
[21] Nick C Fox,et al. Longitudinal Patterns of Regional Change on Volumetric MRI in Frontotemporal Lobar Degeneration , 2004, Dementia and Geriatric Cognitive Disorders.
[22] Karsten Specht,et al. Voxel-based analysis of multiple-system atrophy of cerebellar type: complementary results by combining voxel-based morphometry and voxel-based relaxometry , 2005, NeuroImage.
[23] J. Ashburner,et al. Progression of structural neuropathology in preclinical Huntington’s disease: a tensor based morphometry study , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[24] B. Harper. Huntington Disease , 2005, Journal of the Royal Society of Medicine.
[25] David S Tuch,et al. Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures , 2006, Movement disorders : official journal of the Movement Disorder Society.
[26] Andrea Ciarmiello,et al. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[27] Jane S. Paulsen,et al. Preparing for preventive clinical trials: the Predict-HD study. , 2006, Archives of neurology.
[28] F. Cendes,et al. Striatal and extrastriatal atrophy in Huntington's disease and its relationship with length of the CAG repeat. , 2006, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[29] J. Brandt,et al. The association of CAG repeat length with clinical progression in Huntington disease , 2006, Neurology.
[30] Nick C. Fox,et al. Automated Measurement of Hippocampal Atrophy Using Fluid-Registered Serial MRI in AD and Controls , 2007 .
[31] Wenya Linda Bi,et al. Triplet repeat mutation length gains correlate with cell-type specific vulnerability in Huntington disease brain. , 2007, Human molecular genetics.
[32] F Cendes,et al. Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[33] Stefan Klöppel,et al. White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease. , 2008, Brain : a journal of neurology.
[34] Nick C Fox,et al. Automatic classification of MR scans in Alzheimer's disease. , 2008, Brain : a journal of neurology.
[35] Clifford R. Jack,et al. Alzheimer's disease diagnosis in individual subjects using structural MR images: Validation studies , 2008, NeuroImage.
[36] Bruce Fischl,et al. Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. , 2008, Brain : a journal of neurology.
[37] Nick C Fox,et al. Whole‐brain atrophy as a measure of progression in premanifest and early Huntington's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.
[38] Sébastien Ourselin,et al. Issues with threshold masking in voxel-based morphometry of atrophied brains , 2009, NeuroImage.
[39] Nick C Fox,et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data , 2009, The Lancet Neurology.
[40] John Ashburner,et al. Computational anatomy with the SPM software. , 2009, Magnetic resonance imaging.
[41] Michael Weiner,et al. Automated MRI-based classification of primary progressive aphasia variants , 2009, NeuroImage.
[42] Michael Weiner,et al. Comparison of phantom and registration scaling corrections using the ADNI cohort , 2009, NeuroImage.
[43] Chih-Jen Lin,et al. LIBSVM: A library for support vector machines , 2011, TIST.